Shams S, Firouzi A, Zanganehfar ME, Gouran A, Khajali Z. Successful percutaneous intervention in a rare case of aberrant systemic artery to a normal lung presented with hemoptysis.
J Cardiol Cases 2021;
24:122-125. [PMID:
34466175 DOI:
10.1016/j.jccase.2021.02.011]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 02/09/2021] [Accepted: 02/18/2021] [Indexed: 11/28/2022] Open
Abstract
Aberrant systemic artery to the lung without evidence of sequestration is a rare congenital anomaly. Treatment of choice for this anomaly is controversial. A 27-year-old man with bicuspid aortic valve (AV) and a history of AV replacement was admitted to our center with hemoptysis. Aberrant systemic artery to the lung without sequestration was diagnosed. Endovascular closure of aberrant vessel with septal occluder was performed. After 2 years the previous device was embolized to the distal part and he came back with hemoptysis. The second endovascular procedure was performed with a larger device with a successful result. There are surgical and interventional treatment options for systemic arterialization to a normal lung without sequestration. In this case we used Amplatzer septal occluder (St. Jude Medical, Minneapolis, MN, USA) for occlusion of the aberrant vessel. <Learning objective: Systemic arterialization of the lung is a rare congenital anomaly, the treatment of choice for this anomaly is controversial, using septal occluder may be a useful method for management of this anomaly. Here we report a patient with this rare anomaly who had an educational clinical course. The type of management performed is not reported in other articles with similar cases.>.
Collapse